Group A streptococcus

Abbott said that the next-generation molecular POC assays have also been CLIA waived for use on the Abbott ID NOW instrument, formerly called Alere i.

The test, which received FDA clearance in late 2017, runs in as little as 18 minutes.

The firm's Group A Strep test for use on its Sofia2 analyzer also received CLIA waiver from the agency.

Examining five types of bacterial environments in patients' stomachs, researchers found that non-Helicobacter pylori microbiota may lead to gastric cancer development.

The assay is part of a respiratory testing menu that includes assays for Bordetella and Flu A/B & RSV, and NxTAG and Verigene respiratory pathogen panels.

The automated real-time PCR test provides results in as little as 18 minutes.

The Liat point of care system system has launched with four assays, including three respiratory tests and a novel test for Clostridium difficile.

Researchers sequenced and analyzed the genomes of nine new Streptococcus pyogenes isolates involved in throat, pharynx, or other infections in Lebanon.

The firm said that molecular product sales were up 103 percent, driven by the launch of the Solana Group A Strep assay earlier this year.

The FDA go-ahead marks Quidel's fourth MDx test to receive 510(k) clearance for the Solana platform.